Treatment of Tinea Capitis
Oral antifungal therapy is required for the treatment of tinea capitis, with the choice of agent depending on the causative dermatophyte species. 1
Diagnosis
- Confirm diagnosis before treatment through:
- Scalp scrapings, hair pluck, brush or swab samples
- Microscopy with 10-30% potassium hydroxide
- Culture on Sabouraud agar (with cycloheximide)
First-line Treatment
Oral Antifungal Therapy
For Trichophyton species infections:
- Terbinafine is first-line due to higher cure rates 2
- Adults: 250mg daily for 1-2 weeks
- Children: Based on weight (typically 62.5-250mg daily)
For Microsporum species infections:
When to Start Treatment
- In high-risk populations or with typical clinical features (scaling, lymphadenopathy, alopecia, kerion), start treatment immediately without waiting for culture results 1
- Otherwise, ideally wait for microscopy or culture confirmation 1
Adjunctive Topical Therapy
- Topical therapy alone is not recommended for tinea capitis 1
- Use as adjunctive therapy to reduce transmission of spores:
- Selenium sulfide 1% shampoo
- Ketoconazole 2% shampoo
- Povidone-iodine shampoo 1
Second-line Treatment Options
Treatment Duration
- Continue treatment until the infecting organism is completely eradicated 3
- Typical duration for tinea capitis: 4-6 weeks 3
- Treatment should continue for at least one week after clinical resolution 2
Monitoring and Follow-up
- Clinical improvement expected within 1-2 weeks of starting treatment
- The endpoint of treatment should be mycological cure, not just clinical improvement 2
- Consider follow-up mycological examination in resistant or recurrent cases 2
Treatment Failure Considerations
If treatment fails, consider:
- Poor compliance
- Suboptimal absorption
- Relative insensitivity of the organism
- Reinfection 2
Prevention Measures
- Avoid sharing personal items (combs, brushes, hats)
- Screen and treat family members for anthropophilic infections
- Clean shared items with disinfectant 2
Important Caveats
- Although newer antifungals like terbinafine have shorter treatment durations, griseofulvin remains the only FDA-approved treatment for tinea capitis in children 3
- The causative organism should guide treatment choice - this may require adjusting therapy once culture results are available
- Topical antifungal monotherapy is not effective for tinea capitis 4
- Kerions (inflammatory lesions) may benefit from short-term corticosteroids in addition to antifungal therapy 5